Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

12.2%

53 terminated/withdrawn out of 434 trials

Success Rate

87.7%

+1.2% vs industry average

Late-Stage Pipeline

66%

286 trials in Phase 3/4

Results Transparency

52%

195 of 377 completed trials have results

Key Signals

195 with results40 terminated13 withdrawn

Enrollment Performance

Analytics

Phase 3
144(39.6%)
Phase 4
142(39.0%)
Phase 1
62(17.0%)
Phase 2
13(3.6%)
N/A
3(0.8%)
364Total
Phase 3(144)
Phase 4(142)
Phase 1(62)
Phase 2(13)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (434)

Showing 20 of 434 trials
NCT01279850Completed

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)

Role: lead

NCT01773993Completed

Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

Role: lead

NCT01256593Completed

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)

Role: lead

NCT03342690Completed

Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

Role: lead

NCT01191008Completed

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Role: lead

NCT02958527Completed

Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

Role: lead

NCT00538629Completed

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Role: lead

NCT02060487Phase 4Terminated

Effects of Oral Sildenafil on Mortality in Adults With PAH

Role: lead

NCT00448630Completed

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

Role: lead

NCT01302080Completed

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Role: lead

NCT00383019Phase 3Completed

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Role: lead

NCT00424372Phase 3Completed

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

Role: lead

NCT01720524Phase 3Completed

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Role: lead

NCT01150903Completed

Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

Role: lead

NCT02075047Phase 3Terminated

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Role: lead

NCT03768726Phase 3Terminated

Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder

Role: lead

NCT00351611Phase 4Completed

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Role: lead

NCT00406315Phase 4Completed

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Role: lead

NCT00139776Phase 4Completed

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Role: lead

NCT00282464Phase 3Completed

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

Role: lead